|
⚲
|
| Keyboard |
| Xilio Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001840233 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001840233] | |
| 10-Q | [0001840233] | |
| 3 | [0001840233] | |
| 4 | [0001840233] | |
| 8-K | [0001840233] | |
| D | [0001840233] | |
| SC 13D | [0001840233] | |
| SC 13G | [0001840233] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-03-26 | Buy | 5,000 | $8.79 | 43,950 |
|
Xilio Therapeutics Inc XLO
Prefunded Warrants (right to buy) · derivative
|
2026-02-13 | Buy | 3,739,000 | $0.53 | 1,981,670 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-01-02 | Sell | 1,826 | $0.64 | 1,169 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-01-02 | Sell | 7,030 | $0.64 | 4,499 |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-01-01 | Option exercise | 19,375 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-01-01 | Option exercise | 44,250 | ||
|
Xilio Therapeutics Inc XLO
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 19,375 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 16,625 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 44,250 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 5,000 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-01-01 | Option exercise | 16,625 | ||
|
Xilio Therapeutics Inc XLO
Common Stock
|
2026-01-01 | Option exercise | 5,000 | ||
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 451,885 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 95,221 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 668,789 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-12-31 | Grant | 1,500,258 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Series B Warrants (right to buy) · derivative
|
2025-11-26 | Option exercise | 13,335,000 | $0.00 | |
|
Xilio Therapeutics Inc XLO
Prefunded Warrants (right to buy) · derivative
|
2025-11-26 | Option exercise | 13,335,000 | $0.75 | 10,001,250 |
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-11-21 | Disposed to issuer | 45,000 | ||
|
Xilio Therapeutics Inc XLO
Stock Option (right to buy) · derivative
|
2025-11-21 | Grant | 23,786 | ||
| showing 20 of 200 most recent transactions | |||||